Bill > S06925

This bill requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations, and medical assistance programs in New York to provide coverage for FDA-approved or emergency use authorized antiviral COVID-19 therapeutics without annual deductibles or coinsurance. The bill applies to prescription drug coverage and mandates that these medications be covered when prescribed by a licensed healthcare provider authorized to prescribe under New York's education law. Patients will receive the medication at no cost, though they may first be required to use any available manufacturer or government programs that provide the therapeutics at no or reduced cost. The legislation will take effect on the first day of January following its enactment and will apply to all insurance policies and contracts issued, renewed, modified, altered, or amended on or after that date. This bill aims to ensure accessible and affordable COVID-19 treatment for New York residents by eliminating financial barriers to obtaining antiviral therapeutics.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/S6925